AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi, GlaxoSmithKline Pakistan, listed on the Main Board of the Pakistan Stock Exchange, observed a minor decrease in its stock value in today’s trading. The company’s shares were valued at Rs. 99.68, slightly lower than the previous weighted average rate of Rs. 101.39. GlaxoSmithKline Pakistan has a paid-up capital of 3,184.67 million rupees and saw a turnover of 4,915,500 shares. The pharmaceutical giant, established in 1953, reported earnings per share of 7.73 for the year 2022/2023.
Check Also
PSX Issues Buy-Back Directive for Three Companies Over Regulatory Non-Compliance
Karachi: The Pakistan Stock Exchange (PSX) has issued a compulsory buy-back directive to the sponsors and majority shareholders of three companies, following their continued failure to comply with specific financial regulations. The companies have bee...
The post PSX Issues Buy-Back Directive for Three Companies Over Regulatory Non-Compliance appeared first on .